cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

Cited by (1,002)

Items 601–700 of 1,002

1. Lipoprotein(a) in plasma, arterial wall, and thrombus from patients with aortic aneurysm
   Emmanouel Papagrigorakis, Dimitrios Iliopoulos, Panayiotis J. Asimacopoulos, Hazim J. Safi, Donald Weilbaecher, Karima K. Ghazzaly, Mauro L. Nava, John W. Gaubatz, Joel D. Morrisett · 1997 · Clinical Genetics
2. Learning about the structure and biology of human lipoprotein [a] through dissection by enzymes of the elastase family: facts and speculations
   Antonio Mario Scanu, Celina Edelstein · 1997 · Journal of Lipid Research
3. The relationship between lipoprotein(a) and the complications of diabetes mellitus
   Marlys L. Koschinsky, Santica M. Marcovina · 2003 · Acta Diabetologica
4. Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein(a)
   Ib Christian Klausen, Finn Erland Nielsen, László Dávid Hegedűs · 1992 · Metabolism
5. Detection and quantitation of apolipoprotein(a) mRNA in human liver and its relationship with plasma lipoprotein(a) concentration
   David P. Wade, Brian L. Knight, K. Harders-Spengel · 1991 · Atherosclerosis
6. Amino acids of the recombinant kringle 1 domain of human plasminogen that stabilize its interaction with .omega.-amino acids
   Gordon J. Hoover, Nick Menhart, Andrew Martin · 1993 · Biochemistry
7. The immediate effect of streptokinase on serum lipoprotein(a) concentration and the effect of myocardial infarction on serum lipoprotein(a), apolipoproteins A1 and B, lipids and C-reactive protein
   Anthony David Mbewu, Paul N. Durrington, S. Bulleid · 1993 · Atherosclerosis
8. The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae -specific IgG antibodies
   C Glader · 2000 · European Heart Journal
9. In vivo fate and scavenger receptor recognition of oxidized lipoprotein[a] isoforms in rats.
   YB de Rijke, Günther Jürgens, Esther M. A. J. HESSELS · 1992 · Journal of Lipid Research
10. Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.
    Olga Klezovitch, Celina Edelstein, Antonio Mario Scanu · 1996 · Journal of Clinical Investigation
11. Lipoprotein(a) in diet-induced atherosclerosis in nonhuman primates.
    Ralph L. Nachman, Dov Gavish, Neal Azrolan · 1991 · Arteriosclerosis and Thrombosis A Journal of Vascular Biology
12. Beyond Low-Density Lipoprotein Cholesterol
    Robert S. Rosenson · 1996 · Archives of Internal Medicine
13. Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator
    Michael B. Boffa, Marlys L. Koschinsky · 2013 · Current Atherosclerosis Reports
14. Lipids in health and disease
    Joshua M. Finkelstein, Marie-Thérèse Heemels, Sadaf Shadan, Ursula Keller Weiss · 2014 · Nature
15. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives
    Min Wu, Kaizu Xu, Yulong Guo, J. Yu, Y. Wu, Liming Lin · 2019 · Cardiovascular Drugs and Therapy
16. The role of lipoprotein (a) in pregnancies complicated by pre-eclampsia
    Gwendolyn T. R. Manten, Ytje Y. van der Hoek, J. Marko Sikkema · 2004 · Medical Hypotheses
17. The role of β2-glycoprotein I (β2GPI) in the activation of plasminogen
    Francisco López-Lira, Luis Rosales-León, Verónica Martínez · 2006 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
18. High Levels of Inflammatory Biomarkers Are Associated with Increased Allele-Specific Apolipoprotein(a) Levels in African-Americans
    Erdembileg Anuurad, Jill Rubin, Alan T. Chiem, Russell P. Tracy, Thomas A. Pearson, Lars Berglund · 2008 · The Journal of Clinical Endocrinology & Metabolism
19. Assembly of Lipoprotein (a) in Transgenic Rabbits Expressing Human Apolipoprotein (a)
    Jianglin Fan, Masahiro Araki, Lihua Wu, Mireille Challah, Hiroaki Shimoyamada, Richard M. Lawn, Hirotoshi Kakuta, Hisakata Shikama, Teruo Watanabe · 1999 · Biochemical and Biophysical Research Communications
20. Inhibitors for the In Vitro Assembly of Lp(a)
    Saša Frank, Srdan Durovic, Karam Kostner, Gert M. Kostner · 1995 · Arteriosclerosis Thrombosis and Vascular Biology
21. Apolipoprotein(a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease
    Hiroshi Amemiya, Tadao Arinami, S. Kikuchi, Kimiko Yamakawa‐Kobayashi, L. Li, Hideomi Fujiwara, Michiaki Hiroe, Fumiaki Marumo, Hideo Hamaguchi · 1996 · Atherosclerosis
22. A brief history of lipid and lipoprotein measurements and their contribution to clinical chemistry
    Judith R McNamara, G. Russell Warnick, Gerald R. Cooper · 2006 · Clinica Chimica Acta
23. LPA gene: interaction between the apolipoprotein(a) size (‘kringle IV’ repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein level
    Oddveig Røsby, K. Berg · 2000 · Journal of Internal Medicine
24. Suppression of Colorectal Cancer Liver Metastasis and Extension of Survival by Expression of Apolipoprotein(a) Kringles
    Hyun-Kyung Yu, Jang-Seong Kim, Ho-Jeong Lee, Jin-Hyung Ahn, Suk-Keun Lee, Soon Won Hong, Yeup Yoon · 2004 · Cancer Research
25. Chemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein
    Liang‐Yin Ke, David A. Engler, Jonathan Xuhai Lu, Risë K. Matsunami, Hua‐Chen Chan, Guei‐Jane Wang, Chao-Yuh Yang, Jan‐Gowth Chang, Chu‐Huang Chen · 2011 · Pure and Applied Chemistry
26. Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance
    Harry J. Robberecht, Nina Hermans · 2016 · Metabolic Syndrome and Related Disorders
27. Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction
    Eberhard von Hodenberg, Jörg Kreuzer, Martina B. Hautmann · 1991 · The American Journal of Cardiology
28. Lipoprotein (a) level in the population in Taiwan: relationship to sociodemographic and atherosclerotic risk factors
    Kuo‐Liong Chien, Yuan‐Teh Lee, Fung‐Chang Sung, Ta‐Chen Su, Hsiu‐Ching Hsu, Ruey Shiung Lin · 1999 · Atherosclerosis
29. Lipoprotein(a), homocysteine, and remnantlike particles: emerging risk factors
    LEO J. SEMAN, Judith R McNamara, Ernst J. Schaefer · 1999 · Current Opinion in Cardiology
30. Induction of oxygen free radical generation in human monocytes by lipoprotein(a)
    Peter Riis Hansen, Arsalan Kharazmi, Matti Jauhiainen · 1994 · European Journal of Clinical Investigation
31. Lipoprotein (a): implication in atherothrombosis
    M. John Chapman, Thierry Huby, Fabienne Nigon · 1994 · Atherosclerosis
32. Modulation of Annexin II by Homocysteine: Implications for Atherothrombosis
    Katherine A. Hajjar, Andrew T. Jacovina · 1998 · Journal of Investigative Medicine
33. Relation between lipoprotein(a) concentrations in patients with acute-phase response and risk analysis for coronary heart disease
    Won‐Ki Min, Jae Ok Lee, Jung Won Huh · 1997 · Clinical Chemistry
34. Effects of dietary fish oil supplementation on platelet aggregability and platelet membrane fluidity in normolipemic subjects with and without high plasma Lp(a) concentrations
    Ernst Malle, Wolfgang Sattler, Elmar J. Prenner, Hans Jörg Leis, Albin Hermetter, Anna Gries, Gerhard Max Kostner · 1991 · Atherosclerosis
35. Genetic and metabolic factors predicting risk of cardiovascular disease in familial hypercholesterolemia
    Tineke Jacoba Smilde · 2001 · The Netherlands Journal of Medicine
36. Transient increase of plasma lipoprotein(a) in patients with unstable angina pectoris. Does lipoprotein(a) alter fibrinolysis?
    S Oshima, Kagehiro Uchida, Takanori Yasu · 1991 · Arteriosclerosis and Thrombosis A Journal of Vascular Biology
37. Fibrinolytic parameters and lipoprotein (a) levels in plasma of patients with coronary artery disease
    Luis Javier Garcia Frade, J.J. Alvarez, Isabel Rayo · 1991 · Thrombosis Research
38. Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d’Athérosclérose (NSFA)
    Vincent Durlach, Dominique Bonnefont‐Rousselot, Franck Boccara, Mathilde Varret, Mathilde Di Filippo, Bertrand Cariou, René Valéro, Sybil Charrière, Michel Farnier, Pierre‐Emmanuel Morange et al. · 2021 · Archives of cardiovascular diseases
39. LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study
    Alexandria M. Doerfler, So Hyun Park, Julia M. Assini, Amer Youssef, Lavanya Saxena, Adam B. Yaseen, Marco De Giorgi, Marcel A. Chuecos, Ayrea E. Hurley, Ang Li et al. · 2022 · Molecular Therapy — Methods & Clinical Development
40. Apheresis in Coronary Heart Disease With Elevated Lp (a): A Review of Lp (a) As a Risk Factor and Its Management
    Christiane Keller · 2007 · Therapeutic Apheresis and Dialysis
41. Oleate stimulates the formation of triglyceride-rich particles containing APOB100-APO(a) in long-term primary cultures of human hepatocytes
    Celina Edelstein, Nicholas O. Davidson, Angelo M. Scanu · 1994 · Chemistry and Physics of Lipids
42. Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaques
    Tjark Reblin, Nicolette Meyer, Christine Labeur, Doris Henne‐Bruns, Ulrike Beisiegel† · 1995 · Atherosclerosis
43. Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease
    Ulf Lundstam, Johan D. Herlitz, Thomas Karlsson · 2002 · Journal of Internal Medicine
44. Factor XIIIa Cross-links Lipoprotein(a) With Fibrinogen and Is Present in Human Atherosclerotic Lesions
    Anne M. Romanic, Anthony J. Arleth, Robert N. Willette · 1998 · Circulation Research
45. The human apolipoprotein(a)/plasminogen gene cluster contains a novel homologue transcribed in liver.
    Christopher D. Byrne, Karen Schwartz, Kelli Meer · 1994 · Arteriosclerosis and Thrombosis A Journal of Vascular Biology
46. Prothrombin Kringle-2 Activates Cultured Rat Brain Microglia
    Jooyoung Ryu, Kyoung‐jin Min, Tai Youn Rhim, Tae Hyong Kim, Hankyoung Pyo, Byung-Kwan Jin, Seung-Up Kim, Ilo Jou, Soung Soo Kim, Eun-hye Joe · 2002 · The Journal of Immunology
47. Apolipoprotein(a): Structure-Function Relationship at the Lysine-Binding Site and Plasminogen Activator Cleavage Site
    Eduardo Anglés‐Cano, Gertrudis Rojas · 2002 · Biological Chemistry
48. 5 Fibrinolysis and atherosclerosis
    Anders Hamsten, Per Olof Eriksson · 1995 · Baillière s Clinical Haematology
49. Kringle 4 of human apolipoprotein[a] shares a linear antigenic site with human catalase.
    Hans Dieplinger, G Gruber, Krisztina Krasznai · 1995 · Journal of Lipid Research
50. Congenital plasminogen deficiency caused by a Ser572 to Pro mutation
    H Azuma, Y Uno, Toshio Shigekiyo · 1993 · Blood
51. Apolipoprotein(a): structure and biology
    Angelo, M. Scanu · 2001 · Frontiers in bioscience
52. Lipoproteins and the haemostatic system in atherothrombotic disorders
    George J. Miller · 1999 · Best Practice & Research Clinical Haematology
53. Close relation between lipoprotein (a) levels and atherothrombotic disease in Japanese subjects >75 years of age
    Kazuomi Kario, Takefumi Matsuo, Masahiro Imiya · 1994 · The American Journal of Cardiology
54. Conserved sequences flank variable tandem repeats in two alleles of the G surface protein of Paramecium primaurelia
    Annik Prat · 1990 · Journal of Molecular Biology
55. Stimulation of Vascular Smooth Muscle Cell Proliferation and Migration by Apolipoprotein(a) Is Dependent on Inhibition of Transforming Growth Factor-β Activation and on the Presence of Kringle IV Type 9
    Caroline H. O’Neil, Michael B. Boffa, Mark A. Hancock, J. Geoffrey Pickering, Marlys L. Koschinsky · 2004 · Journal of Biological Chemistry
56. Long distance runners and body-builders exhibit elevated plasma levels of lipoprotein(a)
    Guillermo Celestino Cardoso-Saldaña, Carlos Posadas, Omar O. Orvanaños · 1994 · Chemistry and Physics of Lipids
57. Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A‐I is protective for the incidence of primary acute myocardial infarction in middle‐aged males. An incident case–control study from Sweden
    Dahlén, Weinehall, Weinehall, Stenlund, Jansson, Hallmans, Huhtasaari, Wall · 1998 · Journal of Internal Medicine
58. Lipoprotein(a), Atherosclerosis, and Apolipoprotein(a) Gene Polymorphism
    Uttam Pati, Nirupma Trehan Pati · 2000 · Molecular Genetics and Metabolism
59. Non-enzymatic glycation of lipoprotein(a) in vitro and in vivo
    Chantal Doucet · 1995 · Atherosclerosis
60. Nonfibrinolytic Functions of Plasminogen
    Victoria A. Ploplis, Francis Castellino · 2000 · Methods
61. Lipoprotein(a) Isoforms Display Differences in Affinity for Plasminogen-Like Binding to Human Mononuclear Cells
    Chantal Kang, Vincent Durlach, Thierry Soulat · 1997 · Arteriosclerosis Thrombosis and Vascular Biology
62. Reduction of serum lipoprotein(a) levels in hyperlipidaemic patients with α-tocopheryl nicotinate
    Akio Noma, Shin Maeda, Masataka Okuno · 1990 · Atherosclerosis
63. Expression of human plasminogen cDNA in a baculovirus vector-infected insect cell system
    Joann Whitefleet-Smith, Elliot D. Rosen, James H. McLinden · 1989 · Archives of Biochemistry and Biophysics
64. Elevated Lipoprotein (a) Levels in Primary Nephrotic Syndrome
    Claire Faucher, Chantal Doucet, Alain Baumelou, John Chapman, C Jacobs, Joëlle Thillet · 1993 · American Journal of Kidney Diseases
65. Cloning, expression, and characterization of human apolipoprotein(a) kringle IV37.
    Philip V. LoGrasso, Susan Cornell-Kennon, Brian R. Boettcher · 1994 · Journal of Biological Chemistry
66. Characterization of five mouse monoclonal antibodies to apolipoprotein[a] from human Lp[a]: evidence for weak plasminogen reactivity.
    H C Guo, Victor W. Armstrong, G. Luc, Claude Billardon, Sylvie Goulinet, Rainer Nustede, Dietrich Seidel, M. John Chapman · 1989 · Journal of Lipid Research
67. Elevated Llpoprotein(A) and Fibrinogen Serum Levels Increase the Cardiovascular Risk in Continuous Ambulatory Peritoneal Dialysis Patients
    Werner Bartens, Matthias A. Nauck, Peter J. Schollmeyer · 1996 · Peritoneal Dialysis International
68. The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein B
    Zbigniew A. Zawadzki, François Tercé, Leo Seman · 1988 · Biochemistry
69. Single Lipoprotein Apheresis Session Improves Cardiac Microvascular Function in Patients With Elevated Lipoprotein(a): Detection by Stress/Rest Perfusion Magnetic Resonance Imaging
    Steffen Bohl, Ursula Kassner, Rahel Eckardt et al. · 2009 · Therapeutic Apheresis and Dialysis
70. Lipoprotein(a) and cardiovascular disease in diabetic patients
    Qibin Qi, Lu Qi · 2012 · Clinical Lipidology
71. Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
    Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, Hisayuki Katsuyama · 2022 · International Journal of Molecular Sciences
72. Identification and heterologous expression of aSarcoptes scabieicDNA encoding a structural antigen with immunodiagnostic potential
    Rosa Casais, Miguel Angel Prieto, Ana Balseiro · 2007 · Veterinary Research
73. Diverse effect of ethnicity on plasma lipoprotein[a] levels in heterozygote patients with familial hypercholesterolemia.
    Eran Leitersdorf, Yechiel Friedlander, Jean‐Marie Bard · 1991 · Journal of Lipid Research
74. Lipoprotein(a) mediates high affinity low density lipoprotein association to receptor negative fibroblasts.
    Gerhard Max Kostner, Harald Grillhofer · 1991 · Journal of Biological Chemistry
75. Apolipoprotein(a) size polymorphism in young adults with ischemic stroke
    Jacqueline Peynet, Jean‐Louis Beaudeux, France Woimant, F Flourié, Veronique Giraudeaux, Éric Vicaut, Jean‐Marie Launay · 1999 · Atherosclerosis
76. The assembly of lipoprotein Lp(a)
    Saša Frank, Srdan Durovic, Gerhard Max Kostner · 1996 · European Journal of Clinical Investigation
77. Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function
    Kostner, Clodi, Bodlaj, Watschinger, Hörl, Kurt Derfler, Kurt Huber · 1998 · European Journal of Clinical Investigation
78. Annexin II
    Carrie M. Brownstein, Domenick J. Falcone, Andrew T. Jacovina · 2001 · Annals of the New York Academy of Sciences
79. Characterization of the cDNA Coding for Mouse Prothrombin and Localization of the Gene on Mouse Chromosome 2
    Sandra J. Friezner Degen, Lorie A. Schaefer, C. Scott Jamison · 1990 · DNA and Cell Biology
80. Serum apolipoprotein(a) correlates with growth hormone levels in Chinese patients with acromegaly
    K LAM, Richard W. C. Pang, Edward Denis Janus, Annie W.C. Kung, Chi Chiu Wang · 1993 · Atherosclerosis
81. Novel Therapeutic Strategy for Atherosclerosis
    Ryuichi Morishita, Shingo Yamada, Kei Yamamoto, Naruya Tomita, Iwao Kida, Ikunosuke Sakurabayashi, Akira Kikuchi, Yasufumi Kaneda, Richard M. Lawn, Jitsuo Higaki et al. · 1998 · Circulation
82. Therapeutic Potential of Lipoprotein(a) Inhibitors
    Stephen James Nicholls · 2024 · Drugs
83. Interaction of Genetic Risk Factors Confers Higher Risk for Thrombotic Stroke in Male Chinese: A Multicenter Case‐Control Study
    Chun‐Duo Shen, Weili Zhang, Kai Sun, Yi‐Bo Wang, Yisong Zhen, Rutai Hui · 2007 · Annals of Human Genetics
84. Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options
    Panagiotis G. Anagnostis, Spyridon Ν. Karras, Irene V. Lambrinoudaki, John C. Stevenson, Dimitrios G. Goulis · 2016 · International Journal of Clinical Practice
85. Is Lp(a) ready for prime time use in the clinic? A pros-and-cons debate
    Karam Kostner, Gert M. Kostner, Anthony S. Wierzbicki · 2018 · Atherosclerosis
86. Lipoprotein (a): Recent Updates on a Unique Lipoprotein
    Anum Saeed, Sina Kinoush, Salim S. Virani · 2021 · Current Atherosclerosis Reports
87. Lipoprotein (a): When to Measure and How to Treat?
    David Rhainds, Mathieu R. Brodeur, Jean‐Claude Tardif · 2021 · Current Atherosclerosis Reports
88. Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion
    Amer Youssef, Justin R. Clark, Santica M. Marcovina, Michael B. Boffa, Marlys L. Koschinsky · 2022 · Arteriosclerosis Thrombosis and Vascular Biology
89. Estrogen attenuates vascular remodeling in Lp(a) transgenic mice
    Futoshi Nakagami, Hironori Nakagami, Mariana Kiomy Osako · 2010 · Atherosclerosis
90. Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation
    Jan Eritsland, Harald Arnesen, K. Berg, Ingebjørg Seljeflot, Michael Abdelnoor · 1995 · Scandinavian Journal of Clinical and Laboratory Investigation
91. Lipoprotein (a), LPA Ile4399Met, and Fibrin Clot Properties
    Charles M. Rowland, Clive R. Pullinger, May M. Luke · 2014 · Thrombosis Research
92. The Potential Mechanism for the Effect of Heparin on Tissue Plasminogen Activator–Mediated Plasminogen Activation
    Jun Feng Liang, Yongtao Li, Victor Chi-Min Yang · 2000 · Thrombosis Research
93. Motifs Resembling Hepatocyte Nuclear Factor 1 and Activator Protein 3 Mediate the Tissue Specificity of the Human Plasminogen Gene
    Germana Meroni, Giorgio Buraggi, Roberto Mantovani, Roberto Taramelli · 1996 · European Journal of Biochemistry
94. Increased plasminogen activator inhibitor-1 and apolipoprotein (a) in coronary atherectomy specimens in acute coronary syndromes
    Joji Shindo, Toshiyuki Ishibashi, Mikihiro Kijima et al. · 2001 · Coronary Artery Disease
95. Identification and partial characterization of two classes of receptors for human hepatocyte growth factor on adult rat hepatocytes in primary culture.
    N Arakaki, S Hirono, T Ishii · 1992 · Journal of Biological Chemistry
96. The increased plasma Lp(a) : B lipoprotein particle concentration in angina pectoris is not associated with hypofibrinolysis
    Marie‐Christine Alessi, H J Parra, Patrick Joly · 1990 · Clinica Chimica Acta
97. The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target
    Marlys L. Koschinsky, Florian Kronenberg · 2022 · Atherosclerosis
98. Higher serum uric acid and lipoprotein(a) are correlated with coronary spasm
    Masami Nishino, Naoki Mori, Takahiro Yoshimura, Daisuke Nakamura, Yasuharu Matsunaga‐Lee, Masayuki Taniike, Nobuhiko Makino, Hiroyasu Kato, Yasuyuki Egami, Ryu Shutta et al. · 2013 · Heart and Vessels
99. Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma
    Mario Uccello, Giulia Malaguarnera, Elisa M Pelligra, Antonio Biondi, Francesco Basile, Massimo Motta · 2011 · Indian Journal of Medical and Paediatric Oncology
100. Lipoprotein a and cardiovascular disease current state and future directions for an enigmatic lipoprotein
     Salim S. Virani · 2017 · Frontiers in bioscience